Northern Trust Corp Imago Bio Sciences, Inc. Transaction History

Northern Trust Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$15.03 - $35.96 $168,245 - $402,536	11,194 Added 4.48%	260,917 $9.38 Million
Q3 2022 Nov 14, 2022	BUY	$14.15 - $19.5 $349,674 - $481,884	24,712 Added 10.98%	249,723 $3.76 Million
Q2 2022 Aug 12, 2022	BUY	$11.81 - $20.92 $574,887 - $1.02 Million	48,678 Added 27.61%	225,011 $3.01 Million
Q1 2022 May 13, 2022	BUY	$16.97 - $25.0 $1.17 Million - $1.73 Million	69,211 Added 64.61%	176,333 $3.4 Million
Q4 2021 Feb 08, 2022	BUY	$16.22 - $29.69 $347,318 - $635,751	21,413 Added 24.98%	107,122 $2.54 Million
Q3 2021 Nov 15, 2021	BUY	$16.0 - $28.84 $1.37 Million - $2.47 Million	85,709 New	85,709 $1.72 Million

19.3K

Ticker IMGO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,741,600
Description
Imago BioSciences, Inc., a clinical stage biopharmaceutical company, discovers and develops small molecule product candidates that target lysine-specific demethylase 1(LSD1), an enzyme that used in the production of blood cells in the bone marrow. Its lead product candidate is bomedemstat, which is in Phase II clinical trials for the treatment o...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.